---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004506"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T00:58:15.223737+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "medium"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals files prospectus supplement for ATM equity facility

## Summary
- Filed a prospectus supplement on June 27, 2024 for at-the-market offering of common stock through Maxim Group LLC.
- Agreement originally dated Dec 15, 2023, and amended March 8, 2024; no changes to terms disclosed.
- Polsinelli PC legal opinion on share validity filed as Exhibit 5.1.
- No sales amounts or proceeds reported; facility remains available for use.

## SEC filing metadata
- accession: 0001683168-24-004506
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316824004506/0001683168-24-004506-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316824004506/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004506
- JSON: https://secwatch.observer/filing/0001683168-24-004506.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004506.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.